{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:58:21Z","timestamp":1787313501715,"version":"build-2736575974"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.lfs.2017.12.015","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T02:41:20Z","timestamp":1512960080000},"page":"88-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":156,"special_numbering":"C","title":["l -Carnitine and heart disease"],"prefix":"10.1016","volume":"194","author":[{"given":"Zhong-Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Bin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8426-0675","authenticated-orcid":false,"given":"Cui-Ying","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2017.12.015_bb0005","doi-asserted-by":"crossref","first-page":"6274854","DOI":"10.1155\/2017\/6274854","article-title":"Efficacy and safety of l-carnitine treatment for chronic heart failure: a meta-analysis of randomized controlled trials","volume":"2017","author":"Song","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2017.12.015_bb0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/01.CIR.65.1.115","article-title":"Effects of systemic hypertension on ischemic and nonischemic regional left ventricular function in awake, unsedated dogs after experimental coronary occlusion","volume":"65","author":"Roan","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2017.12.015_bb0015","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1136\/heartjnl-2016-309458","article-title":"Underuse of beta-blockers in heart failure and chronic obstructive pulmonary disease","volume":"102","author":"Lipworth","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.lfs.2017.12.015_bb0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/MNH.0000000000000147","article-title":"Nonsteroidal antagonists of the mineralocorticoid receptor","volume":"24","author":"Kolkhof","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.lfs.2017.12.015_bb0025","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1517\/14740338.2014.951328","article-title":"Safety of ACE inhibitor therapies in patients with chronic kidney disease","volume":"13","author":"Sidorenkov","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.lfs.2017.12.015_bb0030","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1016\/S0021-9258(19)41323-9","article-title":"Equilibrium constants of the reactions of choline acetyltransferase, carnitine acetyltransferase, and acetylcholinesterase under physiological conditions","volume":"250","author":"Pieklik","year":"1975","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2017.12.015_bb0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0033-0620(97)80037-0","article-title":"Carnitine and its derivatives in cardiovascular disease","volume":"40","author":"Arsenian","year":"1997","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.lfs.2017.12.015_bb0040","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.mayocp.2013.02.007","article-title":"l-Carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis","volume":"88","author":"DiNicolantonio","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.lfs.2017.12.015_bb0045","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.2337\/diacare.25.11.2088","article-title":"Obesity, hypertension, and insulin resistance","volume":"25","author":"Bloomgarden","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2017.12.015_bb0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(09)61794-3","article-title":"The metabolic syndrome","volume":"375","author":"Eckel","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2017.12.015_bb0055","first-page":"169","article-title":"l-Propionyl-carnitine protection of mitochondria in ischemic rat hearts","volume":"88","author":"Di Lisa","year":"1989","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.lfs.2017.12.015_bb0060","first-page":"H742","article-title":"Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts","volume":"267","author":"Allard","year":"1994","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.lfs.2017.12.015_bb0065","first-page":"81","article-title":"Myocardial energetics and the role of micronutrients in heart failure: a critical review","volume":"6","author":"Wong","year":"2016","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"10.1016\/j.lfs.2017.12.015_bb0070","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/bph.12475","article-title":"Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy","volume":"171","author":"Fillmore","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0075","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2217\/17460875.2.4.465","article-title":"Long-chain acyl-CoA synthetases and fatty acid channeling","volume":"2","author":"Mashek","year":"2007","journal-title":"Futur. Lipidol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0080","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.ddmec.2009.02.001","article-title":"Carnitine homeostasis, mitochondrial function, and cardiovascular disease","volume":"6","author":"Sharma","year":"2009","journal-title":"Drug Discov. Today Dis. Mech."},{"key":"10.1016\/j.lfs.2017.12.015_bb0085","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.bbadis.2012.03.009","article-title":"The emerging role of acyl-CoA thioesterases and acyltransferases in regulating peroxisomal lipid metabolism","volume":"1822","author":"Hunt","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2017.12.015_bb0090","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1096\/fasebj.6.15.1464372","article-title":"Carnitine function and requirements during the life cycle","volume":"6","author":"Rebouche","year":"1992","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2017.12.015_bb0095","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1750-1172-7-68","article-title":"Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management","volume":"7","author":"Magoulas","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.lfs.2017.12.015_bb0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10545-012-9488-8","article-title":"Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events","volume":"36","author":"Rasmussen","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.lfs.2017.12.015_bb0105","first-page":"H691","article-title":"Metabolic and mechanical effects using l- and d-carnitine in working swine hearts","volume":"243","author":"Liedtke","year":"1982","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.lfs.2017.12.015_bb0110","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1152\/physrev.1983.63.4.1420","article-title":"Carnitine\u2014metabolism and functions","volume":"63","author":"Bremer","year":"1983","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.lfs.2017.12.015_bb0115","first-page":"533","article-title":"Carnitine metabolism and deficiency syndromes","volume":"58","author":"Rebouche","year":"1983","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.lfs.2017.12.015_bb0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.bi.57.070188.001401","article-title":"Carnitine","volume":"57","author":"Bieber","year":"1988","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.lfs.2017.12.015_bb0125","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0021-9258(18)97445-4","article-title":"The distribution of carnitine, acetylcarnitine, and carnitine acetyltransferase in rat tissues","volume":"240","author":"Marquis","year":"1965","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2017.12.015_bb0130","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/BF00558253","article-title":"Pharmacokinetics of intravenous and oral bolus doses of l-carnitine in healthy subjects","volume":"35","author":"Harper","year":"1988","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0135","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/jn\/121.4.539","article-title":"Metabolic fate of dietary carnitine in human adults: identification and quantification of urinary and fecal metabolites","volume":"121","author":"Rebouche","year":"1991","journal-title":"J. Nutr."},{"key":"10.1016\/j.lfs.2017.12.015_bb0140","first-page":"56","article-title":"Pharmacokinetics of l-carnitine in man following intravenous infusion of dl-carnitine","volume":"17","author":"Welling","year":"1979","journal-title":"Int. J. Clin. Pharmacol. Biopharm."},{"key":"10.1016\/j.lfs.2017.12.015_bb0145","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00614562","article-title":"Pharmacokinetics and safety of l-carnitine infused i.v. in healthy subjects","volume":"34","author":"Uematsu","year":"1988","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0150","first-page":"357","article-title":"Homeostatic equilibrium of l-carnitine family before and after i.v. administration of propionyl-l-carnitine in humans, dogs and rats","volume":"Spec No 3","author":"Marzo","year":"1991","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.lfs.2017.12.015_bb0155","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/clpt.1994.85","article-title":"Effect of intravenous l-carnitine on carnitine homeostasis and fuel metabolism during exercise in humans","volume":"55","author":"Brass","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2017.12.015_bb0160","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0026-0495(71)90063-1","article-title":"Carnitine-14C metabolism in choline-deficient, alloxan-diabetic choline-deficient and insulin-treated rats","volume":"20","author":"Mehlman","year":"1971","journal-title":"Metabolism"},{"key":"10.1016\/j.lfs.2017.12.015_bb0165","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0076-6879(87)43065-6","article-title":"Mammalian sulfur amino acid metabolism: an overview","volume":"143","author":"Griffith","year":"1987","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0170","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF02348559","article-title":"The myocardial distribution and plasma concentration of carnitine in patients with mitral valve disease","volume":"24","author":"Nakagawa","year":"1994","journal-title":"Surg. Today"},{"key":"10.1016\/j.lfs.2017.12.015_bb0175","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0002-9149(89)90653-X","article-title":"Myocardial carnitine in end-stage congestive heart failure","volume":"64","author":"Pierpont","year":"1989","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0180","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0304-4165(91)90228-9","article-title":"Effect of exogenous carnitine on carnitine homeostasis in the rat","volume":"1073","author":"Ruff","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2017.12.015_bb0185","first-page":"246","article-title":"Carnitine metabolism and human carnitine deficiency","volume":"9","author":"Tanphaichitr","year":"1993","journal-title":"Nutrition"},{"key":"10.1016\/j.lfs.2017.12.015_bb0190","first-page":"H585","article-title":"Characterization of carnitine transport in isolated perfused adult rat hearts","volume":"242","author":"Vary","year":"1982","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.lfs.2017.12.015_bb0195","first-page":"H1557","article-title":"Carnitine-acylcarnitine translocase in ischemia: evidence for sulfhydryl modification","volume":"253","author":"Pauly","year":"1987","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.lfs.2017.12.015_bb0200","doi-asserted-by":"crossref","first-page":"16615","DOI":"10.1074\/jbc.R114.563148","article-title":"The pyruvate dehydrogenase complexes: structure-based function and regulation","volume":"289","author":"Patel","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2017.12.015_bb0205","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0925-4439(97)00088-4","article-title":"Regulation of pyruvate dehydrogenase activity and glucose metabolism in post-ischaemic myocardium","volume":"1406","author":"Schoder","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2017.12.015_bb0210","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/nu3080735","article-title":"Metabolic agents that enhance ATP can improve cognitive functioning: a review of the evidence for glucose, oxygen, pyruvate, creatine, and l-carnitine","volume":"3","author":"Owen","year":"2011","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2017.12.015_bb0215","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.bbabio.2008.05.447","article-title":"Impact of short- and medium-chain organic acids, acylcarnitines, and acyl-CoAs on mitochondrial energy metabolism","volume":"1777","author":"Sauer","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2017.12.015_bb0220","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.trsl.2012.10.006","article-title":"Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of l-carnitine","volume":"161","author":"Marcovina","year":"2013","journal-title":"Transl. Res."},{"key":"10.1016\/j.lfs.2017.12.015_bb0225","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuroscience.2004.06.028","article-title":"Acetyl-l-carnitine induces a sustained potentiation of the afterhyperpolarization","volume":"128","author":"Lombardo","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2017.12.015_bb0230","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.tcm.2009.07.001","article-title":"Na\/K-ATPase\u2014an integral player in the adrenergic fight-or-flight response","volume":"19","author":"Bers","year":"2009","journal-title":"Trends Cardiovasc. Med."},{"issue":"Suppl. F","key":"10.1016\/j.lfs.2017.12.015_bb0235","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/eurheartj\/12.suppl_F.88","article-title":"Alpha 1-adrenergic system and arrhythmias in ischaemic heart disease","volume":"12","author":"Kurz","year":"1991","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lfs.2017.12.015_bb0240","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1172\/JCI27167","article-title":"The L-type calcium channel in the heart: the beat goes on","volume":"115","author":"Bodi","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2017.12.015_bb0245","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s13181-013-0301-3","article-title":"l-Carnitine for the treatment of a calcium channel blocker and metformin poisoning","volume":"9","author":"St-Onge","year":"2013","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0250","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/187152508785909546","article-title":"Sodium ion transporters as new therapeutic targets in heart failure","volume":"6","author":"Baartscheer","year":"2008","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"10.1016\/j.lfs.2017.12.015_bb0255","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.bbamcr.2008.10.005","article-title":"Inositol trisphosphate and calcium signalling mechanisms","volume":"1793","author":"Berridge","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2017.12.015_bb0260","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbabio.2010.10.008","article-title":"Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism","volume":"1807","author":"Chevrollier","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2017.12.015_bb0265","first-page":"H25","article-title":"Protective role of adenine nucleotide translocase in O2-deficient hearts","volume":"247","author":"Pande","year":"1984","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.lfs.2017.12.015_bb0270","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.bbadis.2015.01.011","article-title":"Palmitoyl-carnitine increases RyR2 oxidation and sarcoplasmic reticulum Ca2+ leak in cardiomyocytes: role of adenine nucleotide translocase","volume":"1852","author":"Roussel","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2017.12.015_bb0275","doi-asserted-by":"crossref","first-page":"20600","DOI":"10.1007\/s11356-016-7220-1","article-title":"The cardioprotective effects of l-carnitine on rat cardiac injury, apoptosis, and oxidative stress caused by amethopterin","volume":"23","author":"Tousson","year":"2016","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.lfs.2017.12.015_bb0280","first-page":"960","article-title":"Nitric oxide-mediated, endothelium-dependent vasodilation is selectively attenuated in the postischemic extremity","volume":"114","author":"Sternbergh","year":"1993","journal-title":"Surgery"},{"key":"10.1016\/j.lfs.2017.12.015_bb0285","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1021197930694","article-title":"Different pathways for sodium entry in cardiac cells during ischemia and early reperfusion","volume":"242","author":"Baetz","year":"2003","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.lfs.2017.12.015_bb0290","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1113\/jphysiol.2004.073197","article-title":"Voltage dependence of ATP-dependent K+ current in rat cardiac myocytes is affected by IK1 and IK(ACh)","volume":"561","author":"Wellner-Kienitz","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0295","first-page":"R534","article-title":"Tissue-specific changes in fatty acid oxidation in hypoxic heart and skeletal muscle","volume":"305","author":"Morash","year":"2013","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.lfs.2017.12.015_bb0300","first-page":"H1544","article-title":"Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria","volume":"273","author":"Lesnefsky","year":"1997","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.lfs.2017.12.015_bb0305","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0272-6386(03)00115-X","article-title":"The role of carnitine in myocardial dysfunction","volume":"41","author":"Pauly","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.lfs.2017.12.015_bb0310","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1113\/jphysiol.2006.125799","article-title":"New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle","volume":"581","author":"Stephens","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0315","doi-asserted-by":"crossref","first-page":"10223","DOI":"10.1074\/jbc.M113.524314","article-title":"Fatty acid chain elongation in palmitate-perfused working rat heart: mitochondrial acetyl-CoA is the source of two-carbon units for chain elongation","volume":"289","author":"Kerner","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2017.12.015_bb0320","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0735-1097(95)80010-E","article-title":"Effects of l-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the l-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial","volume":"26","author":"Iliceto","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0325","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1067\/mhj.2000.103917","article-title":"Three-year survival of patients with heart failure caused by dilated cardiomyopathy and l-carnitine administration","volume":"139","author":"Rizos","year":"2000","journal-title":"Am. Heart J."},{"key":"10.1016\/j.lfs.2017.12.015_bb0330","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1542\/peds.105.6.1260","article-title":"Metabolic aspects of myocardial disease and a role for l-carnitine in the treatment of childhood cardiomyopathy","volume":"105","author":"Helton","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.lfs.2017.12.015_bb0335","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.biocel.2011.08.008","article-title":"Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart","volume":"43","author":"Lemieux","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0340","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCULATIONAHA.107.702795","article-title":"Metabolic mechanisms in heart failure","volume":"116","author":"Ashrafian","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2017.12.015_bb0345","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.bbamcr.2010.09.006","article-title":"Bioenergetics of the failing heart","volume":"1813","author":"Ventura-Clapier","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2017.12.015_bb0350","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/eurjhf\/hfs172","article-title":"Decreased mitochondrial oxidative phosphorylation capacity in the human heart with left ventricular systolic dysfunction","volume":"15","author":"Stride","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.lfs.2017.12.015_bb0355","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/01.CIR.94.11.2837","article-title":"Fatty acid oxidation enzyme gene expression is downregulated in the failing heart","volume":"94","author":"Sack","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2017.12.015_bb0360","first-page":"91","article-title":"Relation between N-terminal pro-brain natriuretic peptide values and invasively measured left ventricular hemodynamic indices","volume":"8","author":"Gremmler","year":"2003","journal-title":"Exp. Clin. Cardiol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0365","doi-asserted-by":"crossref","first-page":"H2596","DOI":"10.1152\/ajpheart.00215.2008","article-title":"Angiotensin II receptor antagonism reverts the selective cardiac BNP upregulation and secretion observed in myocarditis","volume":"294","author":"Ogawa","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0370","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbrc.2011.07.039","article-title":"Protective action of l-carnitine on cardiac mitochondrial function and structure against fatty acid stress","volume":"412","author":"Oyanagi","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2017.12.015_bb0375","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejphar.2013.03.025","article-title":"Heart dysfunction induced by choline-deficiency in adult rats: the protective role of l-carnitine","volume":"709","author":"Strilakou","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0380","first-page":"595","article-title":"l-Carnitine protects gastric mucosa by decreasing ischemia-reperfusion induced lipid peroxidation","volume":"55","author":"Derin","year":"2004","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0385","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2007.07.016","article-title":"Carnitine and lipoate ameliorates lipofuscin accumulation and monoamine oxidase activity in aged rat heart","volume":"574","author":"Savitha","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0390","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1742-7843.2009.00480.x","article-title":"l-Carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats","volume":"106","author":"O'Brien","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0395","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1097\/HJH.0b013e3283569c5a","article-title":"l-Carnitine prevents the development of ventricular fibrosis and heart failure with preserved ejection fraction in hypertensive heart disease","volume":"30","author":"Omori","year":"2012","journal-title":"J. Hypertens."},{"key":"10.1016\/j.lfs.2017.12.015_bb0400","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.etp.2008.07.004","article-title":"Cisplatin-induced kidney injury in the rat: l-carnitine modulates the relationship between MMP-9 and TIMP-3","volume":"61","author":"Martinez","year":"2009","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0405","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.bpj.2009.07.029","article-title":"Modeling cardiac action potential shortening driven by oxidative stress-induced mitochondrial oscillations in guinea pig cardiomyocytes","volume":"97","author":"Zhou","year":"2009","journal-title":"Biophys. J."},{"key":"10.1016\/j.lfs.2017.12.015_bb0410","doi-asserted-by":"crossref","first-page":"E686","DOI":"10.1152\/ajpendo.00476.2012","article-title":"Lactate oxidation in human skeletal muscle mitochondria","volume":"304","author":"Jacobs","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2017.12.015_bb0415","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart\u2014an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2017.12.015_bb0420","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jacc.2007.09.055","article-title":"Combined metabolomic and proteomic analysis of human atrial fibrillation","volume":"51","author":"Mayr","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0425","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1161\/CIRCULATIONAHA.105.569137","article-title":"Metabolomic identification of novel biomarkers of myocardial ischemia","volume":"112","author":"Sabatine","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2017.12.015_bb0430","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00424-015-1717-1","article-title":"Functional response of the isolated, perfused normoxic heart to pyruvate dehydrogenase activation by dichloroacetate and pyruvate","volume":"468","author":"Jaimes","year":"2016","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.lfs.2017.12.015_bb0435","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0014-2999(95)00442-N","article-title":"Propionyl l-carnitine improvement of hypertrophied rat heart function is associated with an increase in cardiac efficiency","volume":"286","author":"Schonekess","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0440","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1540-8167.1993.tb01232.x","article-title":"Recent insights pertaining to sarcolemmal phospholipid alterations underlying arrhythmogenesis in the ischemic heart","volume":"4","author":"McHowat","year":"1993","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0445","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1089\/ars.2014.5873","article-title":"Abnormal Ca(2+) cycling in failing ventricular myocytes: role of NOS1-mediated nitroso-redox balance","volume":"21","author":"Ziolo","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lfs.2017.12.015_bb0450","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/01.RES.88.2.188","article-title":"Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility","volume":"88","author":"Prestle","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2017.12.015_bb0455","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cpcardiol.2015.01.002","article-title":"Sudden cardiac death","volume":"40","author":"Kuriachan","year":"2015","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0460","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.vph.2016.03.006","article-title":"Atrial fibrillation burden and atrial fibrillation type: clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation","volume":"83","author":"Boriani","year":"2016","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0465","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4070\/kcj.2013.43.12.785","article-title":"Primary carnitine deficiency and cardiomyopathy","volume":"43","author":"Fu","year":"2013","journal-title":"Korean Circ. J."},{"key":"10.1016\/j.lfs.2017.12.015_bb0470","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MED.0b013e328329233b","article-title":"Lecithin: cholesterol acyltransferase\u2014from biochemistry to role in cardiovascular disease","volume":"16","author":"Rousset","year":"2009","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.lfs.2017.12.015_bb0475","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1476-5381.1989.tb11971.x","article-title":"Interaction of palmitoyl carnitine with calcium antagonists in myocytes","volume":"97","author":"Patmore","year":"1989","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0480","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1139\/y91-108","article-title":"The 1990 Merck Frosst Award. Ischemic and reperfusion injury in the heart. Cellular mechanisms and pharmacological interventions","volume":"69","author":"Karmazyn","year":"1991","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2017.12.015_bb0485","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1097\/00000542-200006000-00031","article-title":"Multiple agents potentiate alpha1-adrenoceptor-induced conduction depression in canine cardiac purkinje fibers","volume":"92","author":"Kulier","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.lfs.2017.12.015_bb0490","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/CIRCRESAHA.111.300233","article-title":"Mitochondria and endothelial function","volume":"112","author":"Kluge","year":"2013","journal-title":"Circ. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2017.12.015_bb0495","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/S1010-7940(99)00200-6","article-title":"Cytokines in myocardial injury: impact on cardiac surgical approach","volume":"16","author":"Wan","year":"1999","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.lfs.2017.12.015_bb0500","first-page":"119","article-title":"Endothelial dysfunction in heart failure","volume":"60","author":"Bauersachs","year":"2008","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.lfs.2017.12.015_bb0505","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jsha.2013.11.006","article-title":"Severe reversible myocardial injury associated with aluminium phosphide toxicity: a case report and review of literature","volume":"26","author":"Elabbassi","year":"2014","journal-title":"J. Saudi Heart Assoc."},{"key":"10.1016\/j.lfs.2017.12.015_bb0510","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10557-016-6647-4","article-title":"A moderate carnitine deficiency exacerbates isoproterenol-induced myocardial injury in rats","volume":"30","author":"Giudice","year":"2016","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.lfs.2017.12.015_bb0515","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1001\/jama.282.24.2305","article-title":"Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial","volume":"282","author":"Kahn","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.lfs.2017.12.015_bb0520","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4161\/oxim.3.6.14416","article-title":"Doxorubicin toxicity can be ameliorated during antioxidant l-carnitine supplementation","volume":"3","author":"Alshabanah","year":"2010","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2017.12.015_bb0525","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.drudis.2010.03.014","article-title":"The therapeutic prospects of using l-carnitine to manage hypertension-related organ damage","volume":"15","author":"Mate","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.lfs.2017.12.015_bb0530","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1006\/phrs.2000.0786","article-title":"Propionyl-l-carnitine as protector against adriamycin-induced cardiomyopathy","volume":"43","author":"Sayed-Ahmed","year":"2001","journal-title":"Pharmacol. Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517306525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517306525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:44:18Z","timestamp":1660092258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320517306525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":106,"alternative-id":["S0024320517306525"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2017.12.015","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"l-Carnitine and heart disease","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2017.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}